[Evaluation of GeneXpert MTB/RIF and BACTEC-MGIT 960 for the detection of tuberculosis among pneumoconiosis-associated tuberculosis patients]
- PMID: 31594129
- DOI: 10.3760/cma.j.issn.1001-9391.2019.09.014
[Evaluation of GeneXpert MTB/RIF and BACTEC-MGIT 960 for the detection of tuberculosis among pneumoconiosis-associated tuberculosis patients]
Abstract
Objective: To evaluate the performence of GeneXpert MTB/RIF and BACTEC-MGIT 960 on detecting Mycobacterium tuberculosis and rifampicin resistance for pneumoconiosis-associated tuberculosis patients. Methods: The recruited 133 suspected active pneumoconiosis-associated tuberculosis hospitalized cases, morning sputum samples were collected to do modified L-J culture, conventional proportion method drug susceptibility test, GeneXpert MTB/RIF and BACTEC-MGIT 960. Analyze the sensitivity and specificity of the 133 sputum from patients, the positive rates of patients with tuberculosis in GeneXpert MTB/RIF test, BACTEC-MGIT 960 and modified L-J culture were 37.59%, 34.59% and 30.08% respectively. There was no significant difference among the three tests respectively (P>0.05) . According to the modified L-J culture, the sensitivity of GeneXpert MTB/RIF and BACTEC-MGIT 960 in detecting tuberculosis were 92.5% and 95.0% respectively, and specificity in rifampicin resistance were 86.0% and 91.4% respectively. There was no significant difference between GeneXpert MTB/RIF and BACTEC-MGIT 960 (P>0.05) . According to conventional proportion method drug susceptibility test, the sensitivity of GeneXpert MTB/RIF and BACTEC-MGIT 960 in detecting rifampicin resistance were 90.0% and 100%, and specificity were 92.6% and 96.4%. There was no significant difference between GeneXpert MTB/RIF and BACTEC-MGIT 960 (P>0.05) . Conclusion: The GeneXpert MTB/RIF has good performence of detecting tuberculosis and rifampicin resistance. It has good application value among pneumoconiosis-associated tuberculosis patients.
目的: 探讨结核分枝杆菌/利福平耐药实时荧光定量核酸扩增检测体系(GeneXpert MTB/RIF)和结核分枝杆菌快速培养(BACTEC-MGIT 960)检测技术在尘肺结核诊断及耐药性测定中的应用。 方法: 选择2016年1月~12月期间湖南省胸科医院治疗的133例尘肺并发活动性肺结核病例,采集病人晨痰标本,分别进行改良罗氏培养法、GeneXpert MTB/RIF和BACTEC-MGIT 960检测。以改良罗氏法培养和比例法药敏试验结果为基准,评价GeneXpert MTB/RIF和BACTEC-MGIT 960检测结核分枝杆菌和利福平耐药效能。 结果: GeneXpert MTB/RIF、BACTEC-MGIT 960试验和改良罗氏法培养法检测结核分枝杆菌阳性率分别为37.59%、34.59%和30.08%,3种检测技术检出率无统计学差异(P>0.05)。以改良罗氏法培养为基准,GeneXpert MTB/RIF和BACTEC-MGIT 960检测结核分枝杆菌灵敏度分别为92.5%和95.0%,特异度分别为86.0%和91.4%,2种方法各观察指标间的差异均无统计学意义(P均>0.05)。以比例法药敏试验结果为基准,GeneXpert MTB/RIF和BACTEC-MGIT 960检测利福平耐药性灵敏度分别为90.0%和100.0%,特异度分别为92.6%和96.4%,两种方法各观察指标间的差异均无统计学意义(P均>0.05)。 结论: GeneXpert MTB/RIF检测在尘肺结核诊断中具有较高诊断效能,在实际工作中具有良好的应用价值。.
Keywords: Diagnosis; GeneXpert MTB/RIF; Mycobacterium tuberculosis culture (BACTEC-MGIT 960); Pneumoconiosis; Tuberculosis.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical